Who can use Litfulo(Ritlecitinib)?
Ritlecitinib, an innovative kinase inhibitor, is specifically designed for adults and adolescents aged 12 years and older to effectively treat severe alopecia areata.
Ritlecitinib(Litfulo)
Adolescents aged 12 years and older, as well as adult patients, with alopecia areata.
CATEGORY NAVIGATION
RELATED ARTICLES
Indications for Ritlecitinib
Ritlecitinib is an innovative kinase inhibitor with precise target action, clear indication range, specific...
Tuesday, July 1st, 2025, 13:09
Instructions for Ritlecitinib: action and efficacy, dosage, side effects, precautions
Ritlecitinib is an innovative oral kinase inhibitor that offers a new treatment option for patients with severe...
Monday, June 30th, 2025, 17:42
1 / 1
2 in total
Departments
Contact Medical Consultant
Global Drug
Search
Clinical
recruitment
overseas
medical treatment
Remote
consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly
protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved